Journal article icon

Journal article

Reducing short-acting beta-agonist overprescribing in general practice: Evaluation of a quality improvement programme in East London

Abstract:
Objectives To evaluate the impact of a system-wide quality improvement programme on SABA overprescribing, and to identify the most effective strategies. Methods All general practices within one East London borough received the intervention between October 2020 and March 2023. Practices in two neighbouring boroughs acted as comparators. Intervention practices engaged in quality improvement activities including: electronic alerts flagging patients prescribed ≥12 SABA inhalers/year; generating lists of patients overprescribed SABA to call for review; a summary guideline for clinicians; electronic patient information leaflets. All practices were offered webinar coaching. Prescribing data were collected from electronic health records, and SABA overprescription evaluated through interrupted times series analysis. Content analysis was applied to survey data and conversations with staff. Results During the three-year study period all localities introduced programmes to reduce SABA prescribing. We observed a significant decrease in the proportion of asthma patients prescribed more than 6 SABA/year in the study practices. The COVID pandemic triggered a temporary increase in patients on asthma registers, which persisted for 6 months. When implemented by practices the electronic prescribing alerts were effective: 50% of patients who received an active response reduced to <12 SABA in the following year. Conclusions This quality improvement programme was associated with a reduction in SABA overuse, which could also decrease hospital admissions. Practices required individual coaching to use the electronic tools effectively. Integrated prescribing alerts reduced overprescribing, and collaborative practice cultures supported faster implementation of improvement strategies
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1080/13814788.2026.2619229

Authors

More by this author
Role:
Author
ORCID:
0000-0001-6955-0885
More by this author
Role:
Author
ORCID:
0000-0002-7298-2256
More by this author
Role:
Author
ORCID:
0000-0002-4845-7689
More by this author
Institution:
University of Oxford
Role:
Author


Publisher:
Taylor and Francis Group
Journal:
European Journal of General Practice More from this journal
Volume:
32
Issue:
1
Pages:
2619229-2619229
Publication date:
2026-02-02
DOI:
EISSN:
1751-1402
ISSN:
1381-4788


Language:
English
Keywords:
Pubs id:
2407159
Local pid:
pubs:2407159
Source identifiers:
W7127138827
Deposit date:
2026-04-23
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP